Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Positive on Jubilant Life Sciences, Aurobindo Pharma: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Jubilant Life Sciences and Aurobindo Pharma.

    • Buy YES Bank, ACC, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying YES Bank, ACC and Aurobindo Pharma.

    • Bull's Eye: Buy PFC, SKS Micro, TVS Motor, UPL; sell DHFL, Gati

      Vijay Chopra of enochventures.com recommends buying M&M Financial Services with a target of Rs 250 and Wockhardt with a target of Rs 970.

    • Sell Maruti Suzuki, IndusInd Bank; buy UPL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Maruti Suzuki and IndusInd Bank and advises buying UPL.

    • Sell BEML, Federal Bank, Colgate; buy Auro Pharma: Ashish Kyal

      Ashish Kyal of wavesstrategy.com recommends selling BEML, Federal Bank and Colgate Palmolive and advises buying Aurobindo Pharma.

    • Buy Auro Pharma, IDFC; sell India Cements: Krish Subramamnyam

      Krish Subramamnyam of Altamount Capital is of the viw that one can buy Aurobindo Pharma and IDFC futures and sell India Cements.

    • Buy SBI, Jet Airways, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy State Bank of India, Jet Airways and Aurobindo Pharma.

    • Bull's Eye: Buy RComm, Bata, UPL, Tech Mahindra, SpiceJet

      Vishal Malkan of malkansview.com recommends buying Reliance Communications with a target of Rs 55 and Bata India with a target of Rs 540.

    • Buy Bata India, Gujarat Pipavav, Aurobindo Pharma: Gujral

      Ashwani Gujral, fund manager at ashwanigujral.com is of the view that one can buy Bata India, Gujarat Pipavav Port and Aurobindo Pharma.

    • Buy ICICI Bank, HDIL; sell Aurobindo Pharma: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may buy ICICI Bank and sell Aurobindo Pharma.

    • Sell Titan Company, Auro Pharma, Axis Bank: CA Rudramurthy

      CA Rudramurthy BV of Vachana Investments is of the view that one can sell Titan Company, Aurobindo Pharma and Axis Bank.

    • Sell pharma stocks; buy Hero Moto, Power Grid: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling pharma stocks and advises buying Hero Motocorp and Power Grid.

    • Buy Ashok Leyland, Aurobindo Pharma, HDIL, UPL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Ashok Leyland and Aurobindo Pharma.

    • Bull's Eye: Buy DLF, Havells, LIC Housing, JK Tyre, TVS Motor

      CA Rudramurthy BV of Vachana Investments is of the view that one may buy Aurobindo Pharma with a target of Rs 780.

    • Prefer Ashok Leyland, GSK Cons, Sun Pharma: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Ashok Leyland, Tata Motors, GlaxoSmithKline Consumer Healthcare, Britannia Industries and Sun Pharma.

    • Bull's Eye: Buy SBI, Dish TV, Dalmia Bharat, Ceat, SKS Micro

      aCA Rudramurthy BV of Vachana Investments advises buying United Spirits with a target of Rs 2630.

    • Sell Marico, NCC; buy Tata Steel: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Marico and NCC and advises buying Tata Steel.

    • Bull's Eye: Buy India Cements, Colgate, Voltas; sell LIC Housing

      Jay Thakkar of Sharekhan is of the view that one may sell Apollo Hospital with a target of Rs 1331.

    • Bullish on Aurobindo Pharma; may go to Rs 800: Pankaj Jain

      Pankaj Jain of SW Capital is bullish on Aurobindo Pharma and the stock may go to Rs 800.

    • Aurobindo Pharma may test Rs 780: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert feels that Aurobindo Pharma may test Rs 780.

    • Buy Pipavav Defence, Sadbhav Engineering, Jet Airways: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Pipavav Defence, Sadbhav Engineering and Jet Airways.

    • Buy Ashok Leyland, SKS Micro; sell Aurobindo Pharma: Bissa

      Gaurav Bissa of LKP Securities recommends buying Ashok Leyland and SKS Microfinance and advises selling Aurobindo Pharma.

    • Pick Aurobindo Pharma, Tech Mahindra: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends picking Aurobindo Pharma and Tech Mahindra and feels that Adani Enterprises may test Rs 70.

    • Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.

    • Buy L&T, SBI; LIC Housing may test Rs 475: Yogesh Mehta

      Yogesh Mehta of Motilal Oswal Securities recommends buying Larsen and Toubro and State Bank of India and feels that LIC Housing Finance may hit Rs 475.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347